Fibromyalgia Awareness – WNYT Health BeatPosted on
Watch INTiDYN scientist Dr. Albrecht and Fibromyalgia Task force leader Dr. Sue Shipe discuss the importance of patient empowerment.
INTiDYN publishes landmark NF studyPosted on
INTiDYN scientists discover a potential source driving the formation of Neurofibromatosis lesions.
Podcast Interview with Arlene Barshinger of N-the-QueuePosted on
Arlene Barshinger hosted an in-depth podcast interview with Dr. Rice about fibromyalgia and our research for the program N-the-Queue out of San Francisco. Arlene is a fibromyalgia patient: Click here to listen to the podcast (there is a 7 minute lead...Read More
The INTiDYN Approach to FibromyalgiaPosted on
Nerves, Estrogen, Dr. Mikovits and Paradoxes: The INTiDYN Approach to Fibromyalgia and Chronic Fatigue Syndrome by Cort Johnson September 12, 2014 · www.ProHealth.com Reprinted with the kind permission of Cort Johnson and HealthRising. Last y...Read More
Robert Gerwin MD Editorial about the INTiDYN Fibromyalgia studyPosted on
Fibromyalgia Is Not All In Your Head New Research ConfirmsPosted on
Fibromyalgia Is Not All In Your Head, New Research Confirms Researchers discover a rational biological source of pain in the skin of patients with fibromyalgia [June 14, 2013, Rensselaer, NY] – Fibromyalgia, a painful condition affecting approx...Read More
Researchers Discover a Rational Source of Pain in Skin of Fibromyalgia PatientsPosted on
Read the full description here.
NY State (NYCAP) funded INTiDYN keratinocyte researchPosted on
Dr. Albrecht discussing initial NYCAP funding award for keratinocyte research.
Researchers Discover Potential Cause of Chronic Painful SkinPosted on
Skin Cell Target for Pain Discovered Using Novel Translational Research Platform June 6, 2011 – (Rensselaer, N.Y., USA) – A new study may explain why only 50% of patients experiencing chronic nerve pain achieve even partial relief from existi...Read More
INTiDYN Receives STTR Grant From NIHPosted on
Article in The Business Review -- Company also Pens Several New R&D Agreements with Biopharmaceutical Industry -- Rensselaer, NY (April 19, 2011) – Integrated Tissue Dynamics, LLC ("INTiDYN") announced today its receipt of a $300,000 awa...Read More